Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Sequencing data of a novel piperine derivative HJ-23 against colorectal cancer

ABSTRACT: Sequencing data of a novel piperine derivative HJ-23 against colorectal cancer

PROVIDER: PRJNA1145293 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Sequencing data of a novel piperine derivative HJ-23 against colorectal cancer

Project description:In order to explore the mechanism of HJ-23, we used RNA-seq technology to extract and analyze the total RNA of cells treated with DMSO and HJ-23, and analyzed the RNA data.

2025-08-12 | GSE274150 | GEO

Sequencing data of a novel piperine derivative HJ-4 against colorectal cancer

Project description:Sequencing data of a novel piperine derivative HJ-4 against colorectal cancer

| PRJNA1191383 | ENA

Sequencing data of a novel piperine derivative HJ-4 against colorectal cancer

Project description:In order to explore the mechanism of HJ-4, we used RNA-seq technology to extract and analyze the total RNA of cells treated with DMSO and HJ-4, and analyzed the RNA data.

2024-11-28 | GSE282967 | GEO

Thalassospira sp. HJ strain:HJ

Project description:Thalassospira sp. HJ strain:HJ Genome sequencing and assembly

| PRJNA275638 | ENA

A Novel Piperine Derivative Inhibits Colorectal Cancer Progression by Modulating EMT Signaling Pathways: An Integrated Transcriptomic and Machine Learning Analysis

Project description:Colorectal cancer (CRC) is one of the most prevalent and lethal malignancies worldwide. The epithelial-mesenchymal transition (EMT) plays a critical role in tumor invasion and metastasis. Piperine, a natural alkaloid, has demonstrated antitumor activity; however, its low bioavailability limits clinical application. HJJ_3_5, a novel piperine derivative synthesized and validated by our research group, exhibits potent antitumor effects against colorectal cancer cells. In addition to its strong cytotoxicity, HJJ_3_5 disrupts key metastatic processes, including DNA replication, cell migration, invasion, and adhesion, showcasing its multifaceted mechanism of action. In vivo, HJJ_3_5 shows significant efficacy in the CAM model, effectively inhibiting tumor growth and angiogenesis, underscoring its potential as a powerful anti-cancer agent. At the molecular level, comprehensive transcriptomic analysis reveals that HJJ_3_5 significantly downregulates the EMT pathway. Notably, machine learning algorithms identify six core EMT-related genes (COL12A1, PJA2, VCAN, MEF2C, DPYD, and DDR2) as pivotal drivers of cancer progression, with their expression strongly associated with poor clinical outcomes. Single-cell RNA sequencing further reveals that these genes are predominantly expressed in fibroblasts and myofibroblasts, key players in the EMT process and metastasis. These findings position HJJ_3_5 as a promising therapeutic candidate, offering a targeted and potent approach to halting the relentless progression of colorectal cancer.

2024-08-23 | GSE275190 | GEO

Laboratory evolution of S. aureus against a dehydroabietic acid derivative

Project description:Laboratory evolution of S. aureus against a dehydroabietic acid derivative

| PRJEB48687 | ENA

Lacrimispora sp. HJ-01

Project description:Lacrimispora sp. HJ-01 Genome sequencing

| PRJNA1177625 | ENA

Cereibacter sphaeroides strain:HJ

Project description:Cereibacter sphaeroides strain:HJ Genome sequencing

| PRJNA523284 | ENA

Chlamydia psittaci strain:HJ

Project description:Chlamydia psittaci strain:HJ Genome sequencing